STOCK TITAN

[Form 4] Sonos, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. (ticker XRAY) filed a Form 4 reporting that Executive Vice President, Corporate Development, General Counsel & Secretary Richard C. Rosenzweig modestly increased his equity stake on 07/11/2025.

  • 595.34 additional common shares were credited to him as dividend equivalents on previously granted restricted stock units (RSUs). The shares carry the same vesting schedule as the underlying RSUs and were recorded at $0 cost.
  • Following the transaction, Rosenzweig directly owns 84,417.217 common shares.
  • He also received 59.2766 phantom stock units under the company’s Supplemental Executive Retirement Plan (SERP), bringing his total phantom balance to 6,062.0133 units. Each unit is the economic equivalent of one common share and becomes payable in stock upon termination of employment.

No shares were disposed of, and the filing cites automatic dividend reinvestment rather than discretionary open-market purchases. The document was signed on 07/15/2025 by attorney-in-fact Jessica Causey.

DENTSPLY SIRONA Inc. (ticker XRAY) ha presentato un Modulo 4 segnalando che il Vice Presidente Esecutivo, Sviluppo Aziendale, Consigliere Generale e Segretario Richard C. Rosenzweig ha aumentato modestamente la sua partecipazione azionaria il 11/07/2025.

  • Gli sono state accreditate 595,34 azioni ordinarie aggiuntive come equivalenti dividendi su unità azionarie vincolate (RSU) precedentemente assegnate. Le azioni seguono lo stesso calendario di maturazione delle RSU sottostanti e sono state registrate a costo zero.
  • Dopo la transazione, Rosenzweig possiede direttamente 84.417,217 azioni ordinarie.
  • Ha inoltre ricevuto 59,2766 unità di azioni fantasma nell’ambito del Piano di Pensionamento Esecutivo Supplementare (SERP) della società, portando il suo saldo totale di azioni fantasma a 6.062,0133 unità. Ogni unità rappresenta l’equivalente economico di un’azione ordinaria e diventa liquidabile in azioni al termine del rapporto di lavoro.

Non sono state cedute azioni e il documento indica un reinvestimento automatico dei dividendi piuttosto che acquisti discrezionali sul mercato aperto. Il documento è stato firmato il 15/07/2025 dall’avvocato delegato Jessica Causey.

DENTSPLY SIRONA Inc. (símbolo XRAY) presentó un Formulario 4 informando que el Vicepresidente Ejecutivo, Desarrollo Corporativo, Asesor Legal General y Secretario Richard C. Rosenzweig incrementó modestamente su participación accionaria el 11/07/2025.

  • Se le acreditaron 595,34 acciones comunes adicionales como equivalentes a dividendos sobre unidades restringidas de acciones (RSU) previamente otorgadas. Las acciones tienen el mismo calendario de adquisición que las RSU subyacentes y se registraron a costo cero.
  • Tras la transacción, Rosenzweig posee directamente 84,417.217 acciones comunes.
  • También recibió 59.2766 unidades fantasma bajo el Plan Suplementario de Jubilación Ejecutiva (SERP) de la compañía, elevando su saldo total de unidades fantasma a 6,062.0133. Cada unidad es el equivalente económico de una acción común y se paga en acciones al terminar la relación laboral.

No se dispusieron acciones y el informe menciona la reinversión automática de dividendos en lugar de compras discrecionales en el mercado abierto. El documento fue firmado el 15/07/2025 por la apoderada Jessica Causey.

DENTSPLY SIRONA Inc. (티커 XRAY)는 2025년 7월 11일에 부사장 겸 기업 개발 담당, 법률 고문 및 비서인 Richard C. Rosenzweig가 자신의 지분을 소폭 늘렸음을 보고하는 Form 4를 제출했습니다.

  • 기존에 부여된 제한 주식 단위(RSU)에 대한 배당금 상당액으로 595.34주의 추가 보통주가 적립되었습니다. 이 주식들은 기본 RSU와 동일한 베스팅 일정이 적용되며, 비용 없이 기록되었습니다.
  • 거래 후 Rosenzweig는 직접 84,417.217주의 보통주를 보유하게 되었습니다.
  • 또한 회사의 보충 임원 퇴직 연금 계획(SERP)에 따라 59.2766개의 팬텀 스톡 유닛을 받았으며, 총 팬텀 잔액은 6,062.0133 유닛이 되었습니다. 각 유닛은 1주 보통주의 경제적 등가물이며, 고용 종료 시 주식으로 지급됩니다.

주식 처분은 없었으며, 제출 서류에는 임의의 공개 시장 매입이 아닌 자동 배당 재투자가 언급되었습니다. 문서는 2025년 7월 15일 대리인 Jessica Causey가 서명했습니다.

DENTSPLY SIRONA Inc. (symbole XRAY) a déposé un Formulaire 4 indiquant que le Vice-Président Exécutif, Développement Corporatif, Conseiller Juridique Général et Secrétaire Richard C. Rosenzweig a légèrement augmenté sa participation en actions le 11/07/2025.

  • 595,34 actions ordinaires supplémentaires lui ont été créditées en tant qu’équivalents de dividendes sur des unités d’actions restreintes (RSU) précédemment attribuées. Ces actions suivent le même calendrier d’acquisition que les RSU sous-jacentes et ont été enregistrées à coût nul.
  • Après la transaction, Rosenzweig détient directement 84 417,217 actions ordinaires.
  • Il a également reçu 59,2766 unités fantômes dans le cadre du Plan de Retraite Supplémentaire des Cadres (SERP) de la société, portant son solde total d’unités fantômes à 6 062,0133. Chaque unité équivaut économiquement à une action ordinaire et devient payable en actions à la fin de l’emploi.

Aucune action n’a été cédée, et le dépôt cite un réinvestissement automatique des dividendes plutôt que des achats discrétionnaires sur le marché ouvert. Le document a été signé le 15/07/2025 par la mandataire Jessica Causey.

DENTSPLY SIRONA Inc. (Ticker XRAY) reichte ein Formular 4 ein, in dem berichtet wird, dass der Executive Vice President, Corporate Development, General Counsel & Secretary Richard C. Rosenzweig am 11.07.2025 seinen Aktienanteil geringfügig erhöht hat.

  • Es wurden ihm 595,34 zusätzliche Stammaktien als Dividendenäquivalente auf zuvor gewährte Restricted Stock Units (RSUs) gutgeschrieben. Die Aktien unterliegen dem gleichen Vesting-Zeitplan wie die zugrunde liegenden RSUs und wurden mit keinen Kosten verbucht.
  • Nach der Transaktion besitzt Rosenzweig direkt 84.417,217 Stammaktien.
  • Er erhielt außerdem 59,2766 Phantomaktieneinheiten im Rahmen des ergänzenden Executive Retirement Plans (SERP) des Unternehmens, womit sich sein gesamter Phantombestand auf 6.062,0133 Einheiten erhöht. Jede Einheit entspricht wirtschaftlich einer Stammaktie und wird bei Beendigung des Arbeitsverhältnisses in Aktien ausgezahlt.

Es wurden keine Aktien veräußert, und die Meldung nennt eine automatische Dividenden-Reinvestition statt diskretionärer Käufe am offenen Markt. Das Dokument wurde am 15.07.2025 von der Bevollmächtigten Jessica Causey unterzeichnet.

Positive
  • Insider’s direct common share holdings rose by 595.34 shares, reflecting continued equity alignment.
  • No shares were sold, preserving long-term insider ownership.
Negative
  • The acquisitions were automatic dividend equivalents, limiting their signaling value to investors.
  • Transaction size is immaterial relative to the executive’s existing stake and company float.

Insights

TL;DR — Small, automatic dividend RSU credits; neutral to mildly positive signal.

The filing shows a routine credit of 595.34 RSU dividend shares and 59.2766 SERP phantom units to a senior executive. Because the transactions stem from dividend reinvestment rather than open-market buying, the informational value is low. Still, the absence of sales keeps insider sentiment neutral-to-positive, reinforcing alignment with shareholders. Size is immaterial versus both Rosenzweig’s 84k-share stake and XRAY’s ~215 m share float, so market impact should be negligible.

TL;DR — Governance-friendly: no disposals, equity exposure maintained.

From a governance standpoint, dividend reinvestment into RSUs and phantom stock keeps management incentives equity-linked and long-dated. Such mechanisms strengthen pay-for-performance structures without immediate dilution or cash cost. Because the shares vest with the original awards, they maintain existing clawback and forfeiture provisions. However, investors should not interpret the credits as an active expression of confidence, as they are automatic.

DENTSPLY SIRONA Inc. (ticker XRAY) ha presentato un Modulo 4 segnalando che il Vice Presidente Esecutivo, Sviluppo Aziendale, Consigliere Generale e Segretario Richard C. Rosenzweig ha aumentato modestamente la sua partecipazione azionaria il 11/07/2025.

  • Gli sono state accreditate 595,34 azioni ordinarie aggiuntive come equivalenti dividendi su unità azionarie vincolate (RSU) precedentemente assegnate. Le azioni seguono lo stesso calendario di maturazione delle RSU sottostanti e sono state registrate a costo zero.
  • Dopo la transazione, Rosenzweig possiede direttamente 84.417,217 azioni ordinarie.
  • Ha inoltre ricevuto 59,2766 unità di azioni fantasma nell’ambito del Piano di Pensionamento Esecutivo Supplementare (SERP) della società, portando il suo saldo totale di azioni fantasma a 6.062,0133 unità. Ogni unità rappresenta l’equivalente economico di un’azione ordinaria e diventa liquidabile in azioni al termine del rapporto di lavoro.

Non sono state cedute azioni e il documento indica un reinvestimento automatico dei dividendi piuttosto che acquisti discrezionali sul mercato aperto. Il documento è stato firmato il 15/07/2025 dall’avvocato delegato Jessica Causey.

DENTSPLY SIRONA Inc. (símbolo XRAY) presentó un Formulario 4 informando que el Vicepresidente Ejecutivo, Desarrollo Corporativo, Asesor Legal General y Secretario Richard C. Rosenzweig incrementó modestamente su participación accionaria el 11/07/2025.

  • Se le acreditaron 595,34 acciones comunes adicionales como equivalentes a dividendos sobre unidades restringidas de acciones (RSU) previamente otorgadas. Las acciones tienen el mismo calendario de adquisición que las RSU subyacentes y se registraron a costo cero.
  • Tras la transacción, Rosenzweig posee directamente 84,417.217 acciones comunes.
  • También recibió 59.2766 unidades fantasma bajo el Plan Suplementario de Jubilación Ejecutiva (SERP) de la compañía, elevando su saldo total de unidades fantasma a 6,062.0133. Cada unidad es el equivalente económico de una acción común y se paga en acciones al terminar la relación laboral.

No se dispusieron acciones y el informe menciona la reinversión automática de dividendos en lugar de compras discrecionales en el mercado abierto. El documento fue firmado el 15/07/2025 por la apoderada Jessica Causey.

DENTSPLY SIRONA Inc. (티커 XRAY)는 2025년 7월 11일에 부사장 겸 기업 개발 담당, 법률 고문 및 비서인 Richard C. Rosenzweig가 자신의 지분을 소폭 늘렸음을 보고하는 Form 4를 제출했습니다.

  • 기존에 부여된 제한 주식 단위(RSU)에 대한 배당금 상당액으로 595.34주의 추가 보통주가 적립되었습니다. 이 주식들은 기본 RSU와 동일한 베스팅 일정이 적용되며, 비용 없이 기록되었습니다.
  • 거래 후 Rosenzweig는 직접 84,417.217주의 보통주를 보유하게 되었습니다.
  • 또한 회사의 보충 임원 퇴직 연금 계획(SERP)에 따라 59.2766개의 팬텀 스톡 유닛을 받았으며, 총 팬텀 잔액은 6,062.0133 유닛이 되었습니다. 각 유닛은 1주 보통주의 경제적 등가물이며, 고용 종료 시 주식으로 지급됩니다.

주식 처분은 없었으며, 제출 서류에는 임의의 공개 시장 매입이 아닌 자동 배당 재투자가 언급되었습니다. 문서는 2025년 7월 15일 대리인 Jessica Causey가 서명했습니다.

DENTSPLY SIRONA Inc. (symbole XRAY) a déposé un Formulaire 4 indiquant que le Vice-Président Exécutif, Développement Corporatif, Conseiller Juridique Général et Secrétaire Richard C. Rosenzweig a légèrement augmenté sa participation en actions le 11/07/2025.

  • 595,34 actions ordinaires supplémentaires lui ont été créditées en tant qu’équivalents de dividendes sur des unités d’actions restreintes (RSU) précédemment attribuées. Ces actions suivent le même calendrier d’acquisition que les RSU sous-jacentes et ont été enregistrées à coût nul.
  • Après la transaction, Rosenzweig détient directement 84 417,217 actions ordinaires.
  • Il a également reçu 59,2766 unités fantômes dans le cadre du Plan de Retraite Supplémentaire des Cadres (SERP) de la société, portant son solde total d’unités fantômes à 6 062,0133. Chaque unité équivaut économiquement à une action ordinaire et devient payable en actions à la fin de l’emploi.

Aucune action n’a été cédée, et le dépôt cite un réinvestissement automatique des dividendes plutôt que des achats discrétionnaires sur le marché ouvert. Le document a été signé le 15/07/2025 par la mandataire Jessica Causey.

DENTSPLY SIRONA Inc. (Ticker XRAY) reichte ein Formular 4 ein, in dem berichtet wird, dass der Executive Vice President, Corporate Development, General Counsel & Secretary Richard C. Rosenzweig am 11.07.2025 seinen Aktienanteil geringfügig erhöht hat.

  • Es wurden ihm 595,34 zusätzliche Stammaktien als Dividendenäquivalente auf zuvor gewährte Restricted Stock Units (RSUs) gutgeschrieben. Die Aktien unterliegen dem gleichen Vesting-Zeitplan wie die zugrunde liegenden RSUs und wurden mit keinen Kosten verbucht.
  • Nach der Transaktion besitzt Rosenzweig direkt 84.417,217 Stammaktien.
  • Er erhielt außerdem 59,2766 Phantomaktieneinheiten im Rahmen des ergänzenden Executive Retirement Plans (SERP) des Unternehmens, womit sich sein gesamter Phantombestand auf 6.062,0133 Einheiten erhöht. Jede Einheit entspricht wirtschaftlich einer Stammaktie und wird bei Beendigung des Arbeitsverhältnisses in Aktien ausgezahlt.

Es wurden keine Aktien veräußert, und die Meldung nennt eine automatische Dividenden-Reinvestition statt diskretionärer Käufe am offenen Markt. Das Dokument wurde am 15.07.2025 von der Bevollmächtigten Jessica Causey unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Conrad Thomas

(Last) (First) (Middle)
C/O SONOS, INC.
301 COROMAR DRIVE

(Street)
SANTA BARBARA CA 93117

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Sonos Inc [ SONO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Interim CEO
3. Date of Earliest Transaction (Month/Day/Year)
07/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/11/2025 M(1) 29,971 A (2) 165,338 D
Common Stock 07/11/2025 F(3) 14,860 D $11.09 150,478 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (2) 07/11/2025 M(1) 29,971 (4) (4) Common Stock 29,971 $0 0 D
Explanation of Responses:
1. Vesting of restricted stock units ("RSUs") previously granted to the Reporting Person.
2. Each RSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon vesting and settlement for no consideration.
3. Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were withheld by the Issuer in accordance with the agreement governing the RSUs to satisfy federal and state tax withholding obligations of the Reporting Person resulting from the vesting and settlement of RSUs.
4. 1/6 of the shares subject to the RSUs vest in equal installments on each monthly anniversary date following the vesting commencement date of January 13, 2025, until such time as the RSUs are 100% vested, subject to the continuing employment of the Reporting Person as Interim Chief Executive Officer on each vesting date. The RSUs are subject to double-trigger acceleration.
/s/ Rebecca Schuster by power of attorney 07/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many DENTSPLY SIRONA (XRAY) shares did Richard C. Rosenzweig acquire?

595.34 common shares were credited as dividend equivalents on 07/11/2025.

Did the executive sell any XRAY shares in this Form 4?

No. The filing reports only acquisitions; no dispositions occurred.

What is the executive’s total direct XRAY share ownership after the transaction?

Rosenzweig now directly owns 84,417.217 common shares.

What are phantom stock units mentioned in the filing?

Phantom units are SERP credits economically equal to one common share, payable in stock upon employment termination.

Is this insider activity likely to impact XRAY’s stock price?

Given the small, automatic nature of the transaction, market impact is expected to be minimal.
Sonos

NASDAQ:SONO

SONO Rankings

SONO Latest News

SONO Latest SEC Filings

SONO Stock Data

1.31B
117.06M
2.26%
94.74%
5.74%
Consumer Electronics
Household Audio & Video Equipment
Link
United States
SANTA BARBARA